Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care

Conditions

• Type 1 Diabetes
• Diabetes Mellitus, Type 1

Interventions

• DRUG: Outpatient therapy: 11 weeks of drug therapy with usual treatment + 4 weeks of closed-loop therapy

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre